Supplementary Methods

PAGE Cohort Descriptions
Causal Participants have been reexamined 2, 5, 7, 10, 15, and 20 years after baseline; and retention rates across examinations were 91%, 86%, 81%, 79%, 74%, and 72%, respectively.
The CHS is a prospective, population-based cohort study of cardiovascular disease in older adults [3] . In The SHCS is a community-based study of CVD and its risk factors among American Indians, supported by the National Heart, Lung, and Blood Institute (NHLBI) [4, 5] . The family component of the study (SHFS) began in 1998 (phase III) with a pilot study that recruited and examined at least 300 members of 9-2 extended families in each of the three centers (Arizona, South Dakota, Oklahoma). In phase IV of the SHFS, an additional ~900 family members were recruited from each center yielding sample sizes of more than 1,200 participants at each site. In all centers, some individuals are descended from more than one tribe and/or from non-Indian ancestors.
The Women's Health Initiative (WHI) is a prospective cohort study investigating post-menopausal women's health in the U.S [6] . WHI was funded by the National Institutes of Health and the National Heart, Lung, and Blood Institute to study strategies to prevent heart disease, breast cancer, colon cancer, and osteoporotic fractures in women aged 50-79. WHI consists of two parts: randomized clinical trials of hormone therapy, dietary modification, and calcium/Vitamin D supplementation, and an observational cohort study. Subjects for this analysis are 21,000 women drawn from the pool of over 161,000 women involved in either the clinical trial or observational study components of WHI. The 21,000 women were chosen using several selection criteria, which resulted in oversampling women with a BMI > 40, and women belonging to non-white ancestry groups. All selected women were required to have DNA available for analysis.
The Multiethnic Cohort (MEC) is a population-based prospective cohort study of over 215,000 men and women in Hawaii and California aged 45-75 at baseline (1993) (1994) (1995) (1996) and primarily of five ancestries [7] . 
Data collection
BMI:
In EAGLE, all CALiCo studies, and WHI, BMI was calculated from height and weight measured at time of study enrollment in a clinic setting. In WHI only, measurements collected 1 or 3 years after enrollment were substituted for 140 participants missing enrollment height and/or weight. In the MEC, self-reported height and weight were used to calculate baseline BMI.
Smoking status: Current smokers were identified in the MEC, WHI, and ARIC by asking subjects whether they were current smokers and in CHS by asking subjects whether they had smoked in the past 30 days.
In EAGLE, current smoking for NHANES participants was defined by the answer "yes" to the question "do you smoke cigarettes now?" or if cotinine levels were >15ng/ml. In SHS and SHFS, Tobacco exposure was quantified using standardized questionnaires.
Racial/ethnic group:
In all studies, self-reported Racial/ethnic group was collected via questionnaire at baseline.
DNA extraction
In the MEC and WHI, DNA was purified from buffy coat samples. A subset of MEC DNA samples were whole-genome amplified by Molecular Staging Inc. following their standard protocol [11] . For CALiCo, crude cell lysates obtained from Epstein-Barr Virus transformed lymphocyte cell lines [12] . DNA samples from NHANES 1999-2000 and 2001-2002 were purified from blood using standard methods. CALiCo: The majority of genotyping for all sites was performed at the CALiCo central laboratory in
Houston, TX using the TaqMan platform using appropriate duplicates and controls. Genotypes were called using the Applied Biosystem Autocaller 3.1 software, subject to manual review. A subset of CHS and ARIC genotypes (rs10838738, rs1333026, rs2815752, rs3751812, and rs8050136) was obtained from previous GWAS studies [13] using either the Illumina 370CNV BeadChip system (CHS) or the Affymetrix Genome-Wide Human SNP Array 6.0 (Santa Clara, CA) (ARIC). For all genotyping platforms, SNPs were excluded if the minor allele frequency was less than 1%, or if they deviated from Hardy-Weinberg expectations (p < 5x10 -5 
